NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

Embecta Corp. EMBC | NASDAQ

$5.74 $0.08 | 1.41%
SIGNAL:Signal available — unlock to view |2026-09-25 |F&G 73 |RSI 61.4

Company Overview:

Market Cap: $320.69M
Trailing PE: 3.9x
FWD PE *: 3.6x
Payout Ratio (TTM): 31.1%
52-Week Range: $2.77 - $14.91

* Forward PE is based on street estimates.

4.5 Year EMBC Performance Metrics:

Total Return (with DRIP): -85.8% (-35.20% CAGR)
Total Return (no DRIP): -83.0% (-32.51% CAGR)
Share Price: -87.8% (-37.33% CAGR)
Yield on Cost (with DRIP): 0.10%
Total Invested: $10,000
Total Value (with DRIP): $1,420
Total Return $ (with DRIP): -$8,580
Dividend Increase: -93.3% (-49.14% CAGR)
Dividend Yield (FWD): 0.70% ($0.04)
EMBC 4.5-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
EMBC Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
EMBC Price CAGR:1Y: -60.98%2Y: -36.22%5Y: -37.14%10Y: -37.14%
EMBC Dividend Charts
EMBC - Dividends
EMBC Dividend CAGR:1Y: -88.57%2Y: -74.20%5Y: -49.14%10Y: -49.14%
EMBC - Dividend Payout Ratio
EMBC Dividend Payout Ratio CAGR:1Y: -85.13%2Y: -77.95%5Y: 0.00%10Y: 0.00%
EMBC - Dividend to Free Cash Flow Ratio
EMBC Dividend to FCF Ratio CAGR:1Y: -86.31%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

EMBC Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

EMBC - Revenue
EMBC Revenue CAGR:1Y: -8.05%2Y: -0.15%5Y: -1.63%10Y: 0.00%
EMBC - Earnings Per Share (EPS)
EMBC EPS CAGR:1Y: -53.85%2Y: 20.00%5Y: -27.84%10Y: 0.00%
EMBC - Net Income
EMBC Net Income CAGR:1Y: -53.63%2Y: 19.81%5Y: -27.41%10Y: 0.00%
EMBC - EBITDA
EMBC EBITDA CAGR:1Y: -43.85%2Y: -2.93%5Y: -14.36%10Y: 0.00%
EMBC - Free Cash Flow
EMBC Free Cash Flow CAGR:1Y: -49.63%2Y: 0.00%5Y: -19.71%10Y: 0.00%
EMBC - Free Cash Flow / Share
EMBC Free Cash Flow / Share CAGR:1Y: -49.62%2Y: 0.00%5Y: -20.12%10Y: 0.00%
EMBC - Operating Income
EMBC Operating Income CAGR:1Y: -54.10%2Y: -6.66%5Y: -17.09%10Y: 0.00%
EMBC - Gross Profit
EMBC Gross Profit CAGR:1Y: -21.38%2Y: -10.20%5Y: 0.00%10Y: 0.00%
EMBC - Shares Outstanding
EMBC Shares Outstanding CAGR:1Y: 0.03%2Y: 0.58%5Y: 0.52%10Y: 0.00%
EMBC - Share Buybacks
EMBC Share Buybacks CAGR:1Y: 690.91%2Y: 832.74%5Y: 0.00%10Y: 0.00%
EMBC - Stock-Based Comp
EMBC Stock-Based Comp CAGR:1Y: 67.80%2Y: 25.36%5Y: 27.83%10Y: 0.00%
EMBC - Expenses
EMBC Expenses CAGR:1Y: 175.00%2Y: -66.32%5Y: -32.24%10Y: 0.00%
EMBC - Revenue by Segment
EMBC Revenue CAGR:1Y: -8.05%2Y: -0.15%5Y: -1.63%10Y: 0.00%
EMBC - Revenue by Region
EMBC Revenue CAGR:1Y: -8.05%2Y: -0.15%5Y: -1.63%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

EMBC - REVENUE: Actual + Estimates
EMBC Actual Revenue CAGR:1Y: -8.05%2Y: -0.15%5Y: -1.63%10Y: 0.00%
EMBC - EPS: Actual + Estimates
EMBC Actual EPS CAGR:1Y: -53.85%2Y: 20.00%5Y: -27.84%10Y: 0.00%
EMBC - NET INCOME: Actual + Estimates
EMBC Actual Net Income CAGR:1Y: -53.63%2Y: 19.81%5Y: -27.41%10Y: 0.00%
EMBC - EBITDA: Actual + Estimates
EMBC Actual EBITDA CAGR:1Y: -43.85%2Y: -2.93%5Y: -14.36%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

EMBC - Net Profit Margin
EMBC Net Profit Margin CAGR:1Y: -49.55%2Y: 20.06%5Y: -26.20%10Y: 0.00%
EMBC - Gross Profit Margin
EMBC Gross Profit Margin CAGR:1Y: -14.50%2Y: -10.07%5Y: -3.86%10Y: 0.00%
EMBC - Price to Earnings
EMBC Price to Earnings CAGR:1Y: -27.11%2Y: -56.83%5Y: -18.76%10Y: 0.00%
EMBC - Price To Sales Ratio
EMBC Price To Sales Ratio CAGR:1Y: -63.42%2Y: -48.27%5Y: -40.08%10Y: 0.00%
EMBC - Return on Capital Employed
EMBC Return on Capital Employed CAGR:1Y: -52.13%2Y: -3.87%5Y: 0.00%10Y: 0.00%
EMBC - Return on Invested Capital
EMBC Return on Invested Capital CAGR:1Y: -49.60%2Y: 6.39%5Y: 0.00%10Y: 0.00%

Compare stocks side-by-side

EMBC Dividends Info:

Annual Dividend: $0.04
Forward Yield: 0.7%
Ex-Dividend Date: 2026-08-27
Lifetime Dividends / Share: $2.42

EMBC Dividend History: Dates, Payments & Yield list

Below is a schedule of all EMBC dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
08/27/202609/15/2026$0.0100.8%0.79%$5.09
05/28/202606/15/2026$0.0101.2%1.28%$3.13
02/27/202603/17/2026$0.1505.85%6.73%$8.91
12/05/202512/18/2025$0.1505.13%5.12%$11.71
08/29/202509/15/2025$0.1504.14%3.98%$15.08
05/28/202506/13/2025$0.1505.69%6.28%$9.56
02/28/202503/14/2025$0.1504.44%4.56%$13.15
12/06/202412/18/2024$0.1503.12%3.01%$19.92
08/27/202409/13/2024$0.1504.11%3.75%$16.02
05/28/202406/14/2024$0.1504.58%4.69%$12.80
05/24/202406/14/2024$0.1504.57%4.69%$12.80
02/27/202403/15/2024$0.1504.16%4.54%$13.23
12/01/202312/15/2023$0.1503.26%3.46%$17.35
08/24/202309/13/2023$0.1503.54%3.62%$16.58
05/25/202306/13/2023$0.1502.2%2.36%$25.46
02/24/202303/13/2023$0.1501.92%2.07%$29.04
12/29/202201/11/2023$0.1501.16%1.25%$23.98
08/25/202209/14/2022$0.1501.82%1.85%$32.50

Projected Future Returns & Dividends for EMBC

Based on past 4.5-year performance, here are EMBC growth metrics:

Share price CAGR of -37.33%
Dividend CAGR of -49.14%

Using EMBC CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

EMBC (DRIP)EMBC - No DRIP
Current Price$5.74$5.74
Start Shares1,742.161,742.16
Start Value$10,000$10,000
  
After 10 years:
Final Share Count1,799.491,742.16
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$0.05$0.05
Total Dividends$143$142
Final Value$97$235

Estimated Future Value + Dividends - EMBC

NOTE: Above numbers are our estimate based on EMBC's Dividend and Price CAGR over past 4.5 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

Company Info

Embecta Corp. (EMBC) had its IPO on 2022-03-22, and is traded on NASDAQ stock exchange.

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.

EMBC website: https://www.embecta.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)
Loading signals…

DCF Model — EMBC

Value from:
Pay up to today
—
vs current price $5.74
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →